Literature DB >> 7938477

Biological effect of lead-212 localized in the nucleus of mammalian cells: role of recoil energy in the radiotoxicity of internal alpha-particle emitters.

M T Azure1, R D Archer, K S Sastry, D V Rao, R W Howell.   

Abstract

The radiochemical dipyrrolidinedithiocarbamato-212Pb(II) [212Pb(PDC)2] is synthesized and its effects on colony formation in cultured Chinese hamster V79 cells are investigated. The cellular uptake, biological retention, subcellular distribution and cytotoxicity of the radiocompound are determined. The 212Pb is taken up quickly by the cells, reaching saturation levels in 1.25 h. When the cells are washed, the intracellular activity is retained with a biological half-life of 11.6 h. Gamma-ray spectroscopy indicates that the 212Pb daughters (212Bi, 212Po and 208Tl) are in secular equilibrium within the cell. About 72% of the cellular activity localizes in the cell nucleus, of which 35% is bound specifically to nuclear DNA. The mean cellular uptake required to achieve 37% survival is 0.35 mBq of 212Pb per cell, which delivers a dose of 1.0 Gy to the cell nucleus when the recoil energy of 212Bi and 212Po decays is ignored and 1.7 Gy when recoil is included. The corresponding RBE values compared to acute external 137Cs gamma rays at 37% survival are 4.0 and 2.3, respectively. The chemical Pb(PDC)2 is not chemotoxic at the concentrations used in this study. Because the beta-particle emitter 212Pb decays to the alpha-particle-emitting daughters 212Bi and 212Po, these studies provide information on the biological effects of alpha-particle decays that occur in the cell nucleus. Our earlier studies with cells of the same cell line using 210Po (emits 5.3 MeV alpha particle) localized predominantly in the cytoplasm resulted in an RBE of 6. These earlier results for 210Po, along with the present results for 212Pb, suggest that the recoil energy associated with the 212Bi and 212Po daughter nuclei plays little or no role in imparting biological damage to critical targets in the cell nucleus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7938477      PMCID: PMC3321059     

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  16 in total

1.  Effects of different ionizing radiations on human cells in tissue culture. III. Experiments with cyclotron-accelerated alpha-particles and deuterons.

Authors:  G W BARENDSEN; H M WALTER; J F FOWLER; D K BEWLEY
Journal:  Radiat Res       Date:  1963-01       Impact factor: 2.841

2.  The effects of radon daughter alpha-particle irradiation in K1 and xrs-5 CHO cell lines.

Authors:  J D Shadley; J L Whitlock; J Rotmensch; R W Atcher; J Tang; J L Schwartz
Journal:  Mutat Res       Date:  1991-05       Impact factor: 2.433

3.  In vitro exposure of mammalian cells to radon: dosimetric considerations.

Authors:  R F Jostes; T E Hui; A C James; F T Cross; J L Schwartz; J Rotmensch; R W Atcher; H H Evans; J Mencl; G Bakale
Journal:  Radiat Res       Date:  1991-08       Impact factor: 2.841

4.  Radiobiology of alpha particles. III. Cell inactivation by alpha-particle traversals of the cell nucleus.

Authors:  M R Raju; Y Eisen; S Carpenter; W C Inkret
Journal:  Radiat Res       Date:  1991-11       Impact factor: 2.841

5.  Cellular kinetics, dosimetry, and radiobiology of alpha-particle radioimmunotherapy: induction of apoptosis.

Authors:  R M Macklis; J Y Lin; B Beresford; R W Atcher; J J Hines; J L Humm
Journal:  Radiat Res       Date:  1992-05       Impact factor: 2.841

6.  Mutation and inactivation of mammalian cells by various ionising radiations.

Authors:  R Cox; J Thacker; D T Goodhead; R J Munson
Journal:  Nature       Date:  1977-06-02       Impact factor: 49.962

7.  Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments.

Authors:  S M Goddu; R W Howell; D V Rao
Journal:  J Nucl Med       Date:  1994-02       Impact factor: 10.057

8.  Relative biological effectiveness of alpha-particle emitters in vivo at low doses.

Authors:  R W Howell; M T Azure; V R Narra; D V Rao
Journal:  Radiat Res       Date:  1994-03       Impact factor: 2.841

9.  A rapid and reproducible method for the separation of cells from radioactive media.

Authors:  A I Kassis; S J Adelstein
Journal:  J Nucl Med       Date:  1980-01       Impact factor: 10.057

10.  The question of relative biological effectiveness and quality factor for auger emitters incorporated into proliferating mammalian cells.

Authors:  R W Howell; D V Rao; D Y Hou; V R Narra; K S Sastry
Journal:  Radiat Res       Date:  1991-12       Impact factor: 2.841

View more
  11 in total

1.  Bystander effects caused by nonuniform distributions of DNA-incorporated (125)I.

Authors:  Roger W Howell; Anupam Bishayee
Journal:  Micron       Date:  2002       Impact factor: 2.251

2.  In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage.

Authors:  Katia Vandenbulcke; Filip De Vos; Fritz Offner; Jan Philippé; Christos Apostolidis; Roger Molinet; Tuomo K Nikula; Klaus Bacher; Virginie de Gelder; Anne Vral; Christophe Lahorte; Hubert Thierens; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-03       Impact factor: 9.236

Review 3.  Targeted alpha-therapy: past, present, future?

Authors:  Martin W Brechbiel
Journal:  Dalton Trans       Date:  2007-09-11       Impact factor: 4.390

4.  Survival of tumor and normal cells upon targeting with electron-emitting radionuclides.

Authors:  Didier Rajon; Wesley E Bolch; Roger W Howell
Journal:  Med Phys       Date:  2013-01       Impact factor: 4.071

5.  Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.

Authors:  Dongyoul Lee; Mengshi Li; Bryan Bednarz; Michael K Schultz
Journal:  Radiat Res       Date:  2018-06-26       Impact factor: 2.841

6.  Monte Carlo simulation of irradiation and killing in three-dimensional cell populations with lognormal cellular uptake of radioactivity.

Authors:  Roger W Howell; Didier Rajon; Wesley E Bolch
Journal:  Int J Radiat Biol       Date:  2011-11-30       Impact factor: 2.694

7.  Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: relative biological effectiveness of alpha-particle emitters in vivo.

Authors:  R W Howell; S M Goddu; V R Narra; D R Fisher; R E Schenter; D V Rao
Journal:  Radiat Res       Date:  1997-03       Impact factor: 2.841

8.  Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models.

Authors:  Mehran Makvandi; Hwan Lee; Laura N Puentes; Sean W Reilly; Komal S Rathi; Chi-Chang Weng; Ho Sze Chan; Catherine Hou; Pichai Raman; Daniel Martinez; Kuiying Xu; Sean D Carlin; Roger A Greenberg; Bruce R Pawel; Robert H Mach; John M Maris; Daniel A Pryma
Journal:  Mol Cancer Ther       Date:  2019-05-09       Impact factor: 6.261

9.  Towards translation of 212Pb as a clinical therapeutic; getting the lead in!

Authors:  Kwon Yong; Martin W Brechbiel
Journal:  Dalton Trans       Date:  2011-03-04       Impact factor: 4.390

10.  Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model.

Authors:  Kwon Joong Yong; Diane E Milenic; Kwamena E Baidoo; Martin W Brechbiel
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.